Two bronchodilator tablets compared with a placebo.
Gomez J, Gomez G·The Journal of the Royal College of General Practitioners
Abstract not available
Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 1,081–1,100 · 1928 ms
Gomez J, Gomez G·The Journal of the Royal College of General Practitioners
Abstract not available
Krakowski A J·Psychosomatics
Abstract not available
Jones I H·The Medical journal of Australia
Abstract not available
Eisenberg S, Cohen A M·Israel journal of medical sciences
Abstract not available
Reisfield D R, Paret F L·The Journal of the Medical Society of New Jersey
Abstract not available
Singh T, Mehrotra A N, Dhanda P C·The Journal of the Association of Physicians of India
Abstract not available
McDowall A, Owen S, Robin A A·The British journal of psychiatry : the journal of mental science
Abstract not available
Borelli N, Marjerrison G·The American journal of psychiatry
Abstract not available
Savin R C, Turner M C·JAMA
Abstract not available
Mosher L R, Klerman G L, Greaney J F·The American journal of psychiatry
Abstract not available
Friday G A, Feldman E C·Clinical pediatrics
Abstract not available
Timonen S, Hagner M·Annales chirurgiae et gynaecologiae Fenniae
Abstract not available
da Silva J R·Acta tropica. Supplementum
Abstract not available
Pawlowski A, Kostanecki W·Polish medical journal
Abstract not available
Miller R·Die Medizinische Welt
Abstract not available
Traherne J B·The Practitioner
Abstract not available
Neuman M, Demarez J P, Harmey J L, +2 more·International journal of clinical pharmacology research
A strictly controlled clinical trial on a group of 20 patients treated with a time-release preparation of dihydroergotamine compared with 20 on a placebo for the prevention of migraine attacks confirmed that dihydroergotamine was very effective and considered satisfactory by 65% of the patients treated.
Gregersen G, Børsting H, Theil P, +1 more·Acta neurologica Scandinavica
Fifty-nine diabetic patients participated in a double-blind study in order to evaluate the efficiency of myoinositol to improve the function of peripheral nerves. Myoinositol in the amounts given was not able to change motor conduction velocity or vibratory perception threshold. No change in retinopathy and several bio…
Smith E B, Graham J L, Ulrich J A·Southern medical journal
Clotrimazole is a new antifungal agent which is effective topically in dermatophytosis, cutaneous candidiasis, and tinea vesicolor. The authors performed a controlled double-blind clinical trial comparing topical clotrimazole with its vehicle in the treatment of 66 patients with dermatophytic infections of the skin of…
Boyd R J, Burke J F, Colton T·The Journal of bone and joint surgery. American volume
Abstract not available